Polyamyna
St. John's · Founded 2017
About Polyamyna
Polyamyna helps to develop next-generation antimicrobial technologies to prevent infections caused by deadly pathogens, especially ESKAPE bacteria. Their products includes advanced antimicrobial technologies and disinfectant technology. Their customer can contact them through online.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.7M
- Last round: Series Unknown (Sep 2023)
- Website: https://www.polyamyna.ca/
Industries & Categories
Biotechnology, Life Science, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/polyamyna-166868 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.